Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEurocell Regulatory News (ECEL)

Share Price Information for Eurocell (ECEL)

Share Price is delayed by 15 minutes
Get Live Data
109.50    2.00 (1.86%)
Bid:
105.50
Ask:
106.50
Spread: 1.00 (0.948%)
Market Cap: £107.91m
ECEL Live PriceLast checked at - London Stock Exchange

Intraday Eurocell Share Chart

Directorate changes

9 Feb 2026 13:00

RNS Number : 2839S
Eurocell plc
09 February 2026
Β 

9 February 2026

EUROCELL PLC

("Eurocell" the "Group" or the "Company")

Directorate Changes

Β 

Eurocell plc, the leading UK manufacturer and distributor of door and window products to the trade, today announces that Darren Waters will step down as Chief Executive Officer (CEO) with immediate effect. The Board believes that to achieve our strategic objectives in this critical year it is in the best interests of the Company to have surety of leadership and a seamless handover, therefore the Board has appointed Will Truman as CEO commencing immediately.

​Will Truman vacates his role as CFO Designate. Michael Scott has agreed to postpone his retirement and continue as CFO, whilst the Board commences a full and rigorous recruitment process to identify a permanent CFO for the business.

​Derek Mapp, Chair, commented: "On behalf of myself and the Board, I would like to thank Darren for his leadership over the last 3 years, which included the acquisition of Alunet and the expansion and growth of window and door sales through the branches. He has contributed significantly to the culture change we are undertaking in the business. We wish him well in his future endeavours."

Β 

Enquiries:

Β 

Eurocell plc

Will Truman, Chief Executive Officer +44 (0) 1773 842 105

Michael Scott, Chief Financial Officer +44 (0) 1773 842 140

Β 

Teneo

Nick de Bunsen +44 (0) 7825 575 258

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
BOAUKSURNNUURAR
Date   Source Headline
21st Jul 20163:12 pmRNSHolding(s) in Company
30th Jun 20167:00 amRNSAwards to Directors and PDMRs
19th May 20162:43 pmRNSResult of AGM
19th May 20167:00 amRNSAGM Trading Update
21st Apr 20166:04 pmRNSHolding(s) in Company
20th Apr 20167:00 amRNSResult of Placing
19th Apr 20164:36 pmRNSProposed Placing
7th Apr 20163:58 pmRNSConfirmation of CEO Board Change
16th Mar 20167:00 amRNS2015 Full Year Results
9th Mar 20167:00 amRNSAcquisition
26th Jan 20167:04 amRNSDirectorate Change
21st Jan 20167:00 amRNSTrading Statement
1st Dec 20153:06 pmRNSHolding(s) in Company
11th Nov 201510:56 amRNSDirector Declaration
18th Sep 20159:56 amRNSHolding(s) in Company
17th Sep 201511:31 amRNSHolding(s) in Company
17th Sep 201511:29 amRNSHolding(s) in Company
15th Sep 201511:06 amRNSResult of Placing
15th Sep 20157:00 amRNSProposed Placing
25th Aug 20157:00 amRNSHalf Yearly Results
29th May 20152:59 pmRNSChange of Adviser
13th May 20155:32 pmRNSHolding(s) in Company
14th Apr 20157:00 amRNSAppointment of Joint Corporate Brokers
11th Mar 20154:33 pmRNSHolding(s) in Company
11th Mar 20153:17 pmRNSHolding(s) in Company
10th Mar 20157:03 amRNSAnnouncement of Grant Awards
9th Mar 20158:00 amRNSAdmission to Trading on London Stock Exchange
4th Mar 20152:31 pmRNSPublication of Prospectus
4th Mar 20157:00 amRNSAnnouncement of Offer Price

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.